GRAIL, Inc. Common Stock (GRAL) is a publicly traded Healthcare sector company. As of May 21, 2026, GRAL trades at $65.50 with a market cap of $2.61B and a P/E ratio of -6.29. GRAL moved +8.81% today. Year to date, GRAL is -31.04%; over the trailing twelve months it is +67.93%. Its 52-week range spans $12.33 to $118.84. Analyst consensus is buy with an average price target of $67.04. Rallies surfaces GRAL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes GRAL SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $65.50 |
| Market Cap | $2.61B |
| P/E Ratio | -6.29 |
| EPS | $-10.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $118.84 |
| 52-Week Low | $12.33 |
| Volume | 51 |
| Avg Volume | 0 |
| Revenue (TTM) | $156.12M |
| Net Income | $-395.32M |
| Gross Margin | 0.00% |
7 analysts cover GRAL: 0 strong buy, 4 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $67.04.